Guansheng Co.: Clarifying the untrue reports by the media, warning of the risks of stock price overheating.

Guansheng Group announced that recently, some online media have published reports related to "Guansheng Group releasing intelligent bionic joint arms in Shanghai," mentioning that the company's core component business for humanoid robots has entered the commercial mass production stage, etc., which is a misinterpretation by the media. The company's main business is still automotive chassis system components. Currently, the intelligent bionic joint arm products for robots have no orders, have not generated revenue, and have not entered the mass production stage. The company will contact the media to remove false statements and hold them accountable. In addition, the company's stock has risen by 16.07% since January 1, 2026, exceeding the industry and Shanghai Stock Exchange index during the same period, reminding investors to be cautious of risks.